The post Re7 Labs threatens whistleblower over exposure to yield vault collapse appeared on BitcoinEthereumNews.com. Risk “curator” Re7 Labs has sent a cease and desist letter to a “whistleblower,” via its legal representative Pillsbury Winthrop Shaw Pittman LLP. The letter comes in response to accusations that Re7 Labs failed in its responsibility for managing risk in certain vaults. Depositors to these vaults were exposed to last month’s Stream Finance collapse and the subsequent domino-effect that hit similar projects.  The allegations refer to Re7 Labs’ actions before, during, and after the collapse.  The “whistleblower” contacted Protos Leaks on behalf of a group of affected depositors who claim to have lost money lending into Re7 Labs’ tether (USDT) market on Euler Finance, a DeFi lending platform. The allegations In their tip, the whistleblower specifically lists as Re7 Labs’ failings: Asset selection and LTV configuration Monitoring abnormal borrowing or concentration risk Restricting borrowing during suspicious activity Executing liquidations or parameter changes when collateral deteriorates Incident disclosure and communication with users and partners Re7 Labs has taken issue with a previous report, which was forwarded to media outlets and requested the suspension of the fund’s (ultimately unsuccessful) nomination for the HFM European Performance Awards. The report, which also extended to other firms, described an “attacker” borrowing large quantities of USD1 and USDT against USDX. Later, a series of large USDX sales “intentionally” crashed USDX’s price, depleting on-chain liquidity and causing liquidation of the collateral to fail. The funds were allegedly sourced from addresses linked to Stables Labs, the issuer of USDX. It also slams Euler Finance, which it claims “failed to implement safeguards,” and Binance, which was “allegedly unresponsive to requests from victims to freeze” the proceeds. Read more: High yields to haircuts: Has DeFi learned anything from yield vault collapse? The response A representative of Re7 Labs told Protos that the allegations are “serious, inaccurate and unsubstantiated, and… The post Re7 Labs threatens whistleblower over exposure to yield vault collapse appeared on BitcoinEthereumNews.com. Risk “curator” Re7 Labs has sent a cease and desist letter to a “whistleblower,” via its legal representative Pillsbury Winthrop Shaw Pittman LLP. The letter comes in response to accusations that Re7 Labs failed in its responsibility for managing risk in certain vaults. Depositors to these vaults were exposed to last month’s Stream Finance collapse and the subsequent domino-effect that hit similar projects.  The allegations refer to Re7 Labs’ actions before, during, and after the collapse.  The “whistleblower” contacted Protos Leaks on behalf of a group of affected depositors who claim to have lost money lending into Re7 Labs’ tether (USDT) market on Euler Finance, a DeFi lending platform. The allegations In their tip, the whistleblower specifically lists as Re7 Labs’ failings: Asset selection and LTV configuration Monitoring abnormal borrowing or concentration risk Restricting borrowing during suspicious activity Executing liquidations or parameter changes when collateral deteriorates Incident disclosure and communication with users and partners Re7 Labs has taken issue with a previous report, which was forwarded to media outlets and requested the suspension of the fund’s (ultimately unsuccessful) nomination for the HFM European Performance Awards. The report, which also extended to other firms, described an “attacker” borrowing large quantities of USD1 and USDT against USDX. Later, a series of large USDX sales “intentionally” crashed USDX’s price, depleting on-chain liquidity and causing liquidation of the collateral to fail. The funds were allegedly sourced from addresses linked to Stables Labs, the issuer of USDX. It also slams Euler Finance, which it claims “failed to implement safeguards,” and Binance, which was “allegedly unresponsive to requests from victims to freeze” the proceeds. Read more: High yields to haircuts: Has DeFi learned anything from yield vault collapse? The response A representative of Re7 Labs told Protos that the allegations are “serious, inaccurate and unsubstantiated, and…

Re7 Labs threatens whistleblower over exposure to yield vault collapse

Risk “curator” Re7 Labs has sent a cease and desist letter to a “whistleblower,” via its legal representative Pillsbury Winthrop Shaw Pittman LLP.

The letter comes in response to accusations that Re7 Labs failed in its responsibility for managing risk in certain vaults.

Depositors to these vaults were exposed to last month’s Stream Finance collapse and the subsequent domino-effect that hit similar projects. 

The allegations refer to Re7 Labs’ actions before, during, and after the collapse. 

The “whistleblower” contacted Protos Leaks on behalf of a group of affected depositors who claim to have lost money lending into Re7 Labs’ tether (USDT) market on Euler Finance, a DeFi lending platform.

The allegations

In their tip, the whistleblower specifically lists as Re7 Labs’ failings:

  • Asset selection and LTV configuration
  • Monitoring abnormal borrowing or concentration risk
  • Restricting borrowing during suspicious activity
  • Executing liquidations or parameter changes when collateral deteriorates
  • Incident disclosure and communication with users and partners

Re7 Labs has taken issue with a previous report, which was forwarded to media outlets and requested the suspension of the fund’s (ultimately unsuccessful) nomination for the HFM European Performance Awards.

The report, which also extended to other firms, described an “attacker” borrowing large quantities of USD1 and USDT against USDX.

Later, a series of large USDX sales “intentionally” crashed USDX’s price, depleting on-chain liquidity and causing liquidation of the collateral to fail. The funds were allegedly sourced from addresses linked to Stables Labs, the issuer of USDX.

It also slams Euler Finance, which it claims “failed to implement safeguards,” and Binance, which was “allegedly unresponsive to requests from victims to freeze” the proceeds.

Read more: High yields to haircuts: Has DeFi learned anything from yield vault collapse?

The response

A representative of Re7 Labs told Protos that the allegations are “serious, inaccurate and unsubstantiated, and distract from the ongoing legal process and genuine recovery efforts.”

It insists that “responsibility lies with Stream Finance and/or Stables Labs” and that, as a “fellow lender,” it has “also suffered losses.”

The cease and desist letter, seen by Protos, denies any “wrongdoing, misconduct, or breach of any legal or other obligation… in the strongest possible terms.”

As well as the cease and desist demand, the letter also requests a “formal written apology” and corrective statement, confirmation of identity, and the deletion of messages containing the allegations.

Neither response directly addresses the specific claims made by the whistleblower, however. 

Protos sent a follow-up pushing for a response to the specific accusations around collateral selection, and awareness of “abnormal” borrowing, but hasn’t yet received a reply.

Read more: David Sacks sends silly legal threat to the New York Times

Yield vault armageddon

In late October, concerns over a “daisy chain of circular lending” began to circulate among DeFi yield farmers.

Then, on November 4, Stream Finance announced a loss of $93 million, triggering a scramble to withdraw and unwind risky positions across the DeFi yield vault ecosystem.

As confidence in vault tokens such as Stream’s xUSD, Elixir’s deUSD and Stables Labs USDX evaporated, a mass depegging followed.

The tokens had been widely used as collateral to borrow mainstream stablecoins. Along with the collateral’s value, borrowers’ incentive to repay their loans also evaporated.

Some users feel that lending platforms and vault ‘curators’ didn’t do enough to protect depositors, and that risks were opaque. Receipt tokens for stablecoin vaults, many with USD in the name, were seen as pseudo-stablecoins generating yield from “delta-neutral” strategies.

Read more: Stream Finance meltdown: winners and losers in DeFi ‘risk curator’ reckoning

Ultimately, as we saw last cycle, generating high yields on stablecoin deposits requires risky levels of leverage.

Previous statements from Re7 Labs have indicated at least $27 million of exposure to depegged assets deUSD and USDX.

Got a tip? Send us an email securely via Protos Leaks. For more informed news, follow us on X, Bluesky, and Google News, or subscribe to our YouTube channel.

Source: https://protos.com/re7-labs-threatens-whistleblower-over-exposure-to-yield-vault-collapse/

Market Opportunity
Octavia Logo
Octavia Price(VIA)
$0,0152
$0,0152$0,0152
-5,00%
USD
Octavia (VIA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23